Literature DB >> 17484925

Role of post-chemotherapy surgery in germ cell tumors.

Hong Gee Sim1, Paul H Lange, Daniel W Lin.   

Abstract

Surgery after systemic chemotherapy for advanced testicular cancer has maintained its role in staging and therapeutic management. The clinical outcome is strongly influenced by patient selection and extent of extirpative surgery. Although extensive predictive modeling has attempted to define appropriate post-chemotherapy surgical candidates based on various clinical and pathologic parameters, the accuracy of these models remains controversial. Complete removal of all post-chemotherapy residual masses in nonseminomatous germ cell tumors remains the standard of care and allows for improved prognostication of the long-term oncologic and functional outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484925     DOI: 10.1016/j.ucl.2007.02.010

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  9 in total

1.  Post chemotherapy retroperitoneal lymph node dissection in germ cell tumor: robotic way.

Authors:  Girdhar S Bora; Pankaj Panwar; Ravimohan S Mavuduru; Sudheer K Devana; Shrawan K Singh; Arup K Mandal
Journal:  J Robot Surg       Date:  2016-08-08

2.  Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?

Authors:  C Overs; J B Beauval; L Mourey; P Rischmann; M Soulié; M Roumiguié; Nicolas Doumerc
Journal:  World J Urol       Date:  2018-01-20       Impact factor: 4.226

3.  Management of the residual post-chemotherapy retroperitoneal mass in germ cell tumors.

Authors:  Hugh J Lavery; Robert R Bahnson; David S Sharp; Kamal S Pohar
Journal:  Ther Adv Urol       Date:  2009-10

4.  Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis.

Authors:  John P Fitzgerald; Barbara Ercole; Dipen J Parekh
Journal:  Indian J Urol       Date:  2010 Jan-Mar

5.  Outcomes following retroperitoneal lymph node dissection in postchemotherapy residual masses in advanced testicular germ cell tumors.

Authors:  Prabhjot Singh; Siddharth Yadav; Sanjay Mahapatra; Amlesh Seth
Journal:  Indian J Urol       Date:  2016 Jan-Mar

6.  Hepatic metastasectomy for testicular germ cell tumors: is it worth it?

Authors:  Y Nancy You; Bradley C Leibovitch; Florencia G Que
Journal:  J Gastrointest Surg       Date:  2009-02-04       Impact factor: 3.452

Review 7.  Surgical controversies in the management of post-chemotherapy nonretroperitoneal residual disease in metastatic nonseminomatous germ cell tumors.

Authors:  Durgatosh Pandey; Pankaj Kumar Garg; Mukur Dipi Ray; Ashutosh Mishra
Journal:  South Asian J Cancer       Date:  2016 Jan-Mar

8.  Squamous Cell Carcinoma Malignantly Transformed From Frequent Recurrence of a Presacral Epidermoid Cyst: Report of a Case.

Authors:  Xiaocai Wu; Chunqiu Chen; Muqing Yang; Xiaoqi Yuan; Hong Chen; Lu Yin
Journal:  Front Oncol       Date:  2020-04-03       Impact factor: 6.244

9.  Predictors of viable germ cell tumor in postchemotherapeutic residual retroperitoneal masses.

Authors:  Khalid Al Othman; Naif Al Hathal; Alaa Mokhtar
Journal:  Urol Ann       Date:  2014-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.